Pre-application for the NIH-Industry Program: Discovering New Therapeutic Uses for Existing Molecules (X02)

The summary for the Pre-application for the NIH-Industry Program: Discovering New Therapeutic Uses for Existing Molecules (X02) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Pre-application for the NIH-Industry Program: Discovering New Therapeutic Uses for Existing Molecules (X02): The National Center for Advancing Translational Sciences (NCATS) seeks to expand the therapeutics discovery program piloted in 2012, to explore new therapeutic uses for proprietary drug candidates (Agents) across a broad range of human diseases. This innovative program allows investigators to propose new therapeutic uses for Agents from pharmaceutical company partners. A strong application will be supported by scientific evidence that modulation of the Agents target will have a positive impact on the disease/condition. PAR-14-213 encourages X02 pre-applications for the NIH-Industry Program: Discovering New Therapeutic Uses for Existing Molecules.The X02 pre-application is the first step in the application process for PAR-14-212, PAR-14-211 and PAR-14-210; applicants must read all of the companion FOAs. The X02 pre-applications will be evaluated by outside experts. Investigators whose X02 pre-applications are judged to be the most meritorious will be notified of the opportunity to submit a UH2/UH3 under PAR-14-212 or a UH3 application under PAR-14-211 or a UH2/UH3 application under PAR-14-210 in the case of a pediatric indication.

Federal Grant Title:	Pre-application for the NIH-Industry Program: Discovering New Therapeutic Uses for Existing Molecules (X02)
Federal Agency Name:	National Institutes of Health
Grant Categories:	Education Health Income Security and Social Services
Type of Opportunity:	Discretionary
Funding Opportunity Number:	PAR-14-213
Type of Funding:	Grant
CFDA Numbers:	93.103, 93.121, 93.173, 93.242, 93.273, 93.279, 93.350, 93.853, 93.865, 93.866, 93.867
CFDA Descriptions:	Food and Drug Administration_Research; Oral Diseases and Disorders Research; Research Related to Deafness and Communication Disorders; Mental Health Research Grants; Alcohol Research Programs; Drug Abuse and Addiction Research Programs; National Center for Advancing Translational Sciences; Extramural Research Programs in the Neurosciences and Neurological Disorders; Child Health and Human Development Extramural Research; Aging Research; Vision Research
Current Application Deadline:	Jul 15, 2014
Original Application Deadline:	Jul 15, 2014
Posted Date:	May 12, 2014
Creation Date:	May 12, 2014
Archive Date:	Aug 15, 2014
Total Program Funding:
Maximum Federal Grant Award:	none
Minimum Federal Grant Award:	none
Expected Number of Awards:
Cost Sharing or Matching:	No

Applicants Eligible for this Grant: Others (see text field entitled "Additional Information on Eligibility" for clarification)
Independent school districts
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
City or township governments
Native American tribal governments (Federally recognized)
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Public and State controlled institutions of higher education
Special district governments
Small businesses
Native American tribal organizations (other than Federally recognized tribal governments)
Public housing authorities/Indian housing authorities
Private institutions of higher education
For profit organizations other than small businesses
County governments
State governments
Additional Information on Eligibility: Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Link to Full Grant Announcement: http://grants.nih.gov/grants/guide/pa-files/PAR-14-213.html
Grant Announcement Contact: NIH OER Webmaster [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

National Institutes of Health 301-496-3405
Similar Government Grants: • Convener and Organizer of Activities and Engagements Related to Processes, Surveillance, a...; • Development and Maintenance of the Animal Food Regulatory Program Standards (U19) Clinical...; • Use of Digital Health Technologies in Clinical Investigations to Support Drug and Biologic...; • Cooperative Agreement to Support the World Trade Organization's (WTO) Standards and Trade ...; • Cooperative Agreement for Long Term Data Collection on Antimicrobial Use in Animals (U01) ...; • Support for Small Scientific Conference Grant Program; • Cooperative Agreement to Support the World Health Organization (WHO) International Program...; • Clinical Studies of Safety and Effectiveness of Orphan Products
More Grants from the National Institutes of Health: • Promoting Broad Participation in NIDCD's Extramural Workforce through Research Education E...; • HEAL Initiative-Early-Stage Discovery of New Pain Targets Within the Understudied Druggabl...; • Optimizing Behavioral Sleep Interventions for Adolescents and Young Adults (R34 Clinical T...; • Global Infectious Disease Research Training Program (D43 Clinical Trial Optional); • Using Neuromodulation to Characterize the Continuum of Pathophysiology Between Substance U...